Monopar Therapeutics (MNPR) Earnings Date, Estimates & Call Transcripts $36.90 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics Earnings Summary Monopar Therapeutics released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.38, which beat analysts' consensus estimates of -$0.65 by $0.27. With a trailing EPS of -$3.48, Monopar Therapeutics' earnings are expected to decrease next year, from ($1.65) to ($2.51) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportMNPR Upcoming EarningsMonopar Therapeutics' next earnings date is estimated for Friday, August 8, 2025, based on past reporting schedules. Upcoming Q2 Earnings DateAug. 8Before Market OpensEstimatedConsensus EPS (May. 13) -$0.65 Actual EPS (May. 13) -$0.38 Beat By $0.27 Get Monopar Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Monopar Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMNPR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Monopar Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.44-$0.56Q2 20252-$0.55-$0.45-$0.50Q3 20252-$0.54-$0.48-$0.51Q4 20252-$1.06-$0.52-$0.79 Monopar Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/8/2025(Estimated)--------5/13/2025Q1 2025-$0.65-$0.38+$0.27-$0.38--3/31/2025Q4 2024-$0.36-$2.23 -$1.87-$2.23--11/8/2024Q3 2024-$0.46-$0.37+$0.09-$0.37--8/9/2024--$0.09-$0.10 -$0.01-$0.10--5/9/2024Q1 2024-$0.85-$0.50+$0.35-$0.10--3/28/2024Q4 2023-$0.85-$0.60+$0.25-$0.12--11/9/2023Q3 2023-$0.95-$0.70+$0.25-$0.14--8/10/2023Q2 2023-$0.95-$0.80+$0.15-$0.16-- Monopar Therapeutics Earnings - Frequently Asked Questions When is Monopar Therapeutics's earnings date? Monopar Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 8th, 2025 based off last year's report dates. Learn more on MNPR's earnings history. Did Monopar Therapeutics beat their earnings estimates last quarter? In the previous quarter, Monopar Therapeutics (NASDAQ:MNPR) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.27. Learn more on analysts' earnings estimate vs. MNPR's actual earnings. How much profit does Monopar Therapeutics generate each year? Monopar Therapeutics (NASDAQ:MNPR) has a recorded net income of -$8.40 million. MNPR has generated -$3.48 earnings per share over the last four quarters. What is Monopar Therapeutics's EPS forecast for next year? Monopar Therapeutics's earnings are expected to decrease from ($1.65) per share to ($2.51) per share in the next year. More Earnings Resources from MarketBeat Related Companies ARDX Earnings Results ZYME Earnings Results LENZ Earnings Results CVAC Earnings Results CRMD Earnings Results CMRX Earnings Results CDMO Earnings Results CRON Earnings Results PRAX Earnings Results NRIX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:MNPR) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNPR Stock Free MNPR Stock Alerts